Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.00683 | 66 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.58905 | 60 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.62208 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.44041 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.55282 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.89389 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.88012 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.61539 | 60 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.60164 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.55707 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.61868 | 61 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.57308 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.64629 | 61 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.62632 | 61 |